JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2116533, encodeId=287321165339b, content=投稿一天后就变成了under review，想问一下大家是编辑内审还是送外审的意思呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d725625357, createdName=ms2000000214267649, createdTime=Sun Feb 26 13:41:44 CST 2023, time=2023-02-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=885331, encodeId=2e93885331b2, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿后一天就under review，20天不到审稿意见回来，一个审稿人尖锐批评，一个看似给了修改机会，最后还是拒稿，未接收转投，总体而言较难中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小笨蛋, createdTime=Tue Sep 15 00:30:03 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553552, encodeId=a1ee55355201, content=8天 with editor，只说投的文章量大，50-60%的文章不会送审，transfer给了Endocrinology和 Journal of endocrine society。哎，歇菜！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1905, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3f8108629, createdName=xiaobao111, createdTime=Sun Mar 11 21:20:00 CST 2018, time=2018-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571551, encodeId=a9d65e155113, content=审稿速度:3.0 经验分享：于2019年2月26日投稿，一篇meta，然后5月18日直接被拒，三个月啊。编者的建议主要是我纳入的中文文献库（CNKI和万方），他们无法重复。所以纳入中文文献的meta慎投这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0icicabQPFRfglHZr0mpDfC2oYjwL5n0xDc0wODUNEyWJuia9wXP3TnHwrZMktLMl7OQH7ZoUicGQHiclLb373GdibAg/132, createdBy=b44f2541766, createdName=lucifer11, createdTime=Mon May 27 16:57:00 CST 2019, time=2019-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073628, encodeId=bf4b10e3628d6, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管代谢 经验分享：一审一个月，2个审稿人，给的意见都很不错，修回编辑直接决定接收了，文章如果比较新颖，故事说的也比较完整还是很有希望的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1376, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95512077050, createdName=1321f15a85m, createdTime=Wed Nov 24 20:49:29 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582484, encodeId=8c8358248482, content=2020/01/01 revise 速度惊人；修回时间给了两个月454646258 2019-12-29 发表:: 非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers454646258 2019-12-29 00:00:00 发表: 非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers, beContent=454646258 2019-12-29 发表:: 非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers, objectType=tool_impact_factor, channel=null, level=null, likeNumber=961, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Wed Jan 01 00:00:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241699, encodeId=4fdc124169912, content=投稿后，由with editor变成了Under Review，不知道是不是送审了的意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fd51628848, createdName=cq2019, createdTime=Sun Aug 28 22:15:35 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236702, encodeId=ad361236e02e6, content=偏重的研究方向：内分泌;临床内分泌 经验分享：7.16号投稿，8.1号收到回修意见，比较友好，审稿人1只要求修改两个具有语法问题的句子，希望最后能接受吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f715652243, createdName=ms9000000283662601, createdTime=Fri Aug 05 08:32:37 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200334, encodeId=be5122003344b, content=3-30投稿，4-5under review，4-24 with editor，希望有revise, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7bfb2469150, createdName=jolin_story_47656629, createdTime=Thu Apr 25 12:38:44 CST 2024, time=2024-04-25, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1054662, encodeId=43b91054662ed, content=审稿速度:1.0 经验分享：一审一个月，两个审稿人，提的问题都很友善，提交返修后两周接收。补充材料需要上传至公共数据库并且在文中引用（第一次投稿时可以不上传）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=680, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6ec5497373, createdName=ms2000000907990850, createdTime=Sat Sep 25 10:21:26 CST 2021, time=2021-09-25, status=1, ipAttribution=)]

2023-02-26 ms2000000214267649 来自江苏省

投稿一天后就变成了under review，想问一下大家是编辑内审还是送外审的意思呀？

135 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2116533, encodeId=287321165339b, content=投稿一天后就变成了under review，想问一下大家是编辑内审还是送外审的意思呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d725625357, createdName=ms2000000214267649, createdTime=Sun Feb 26 13:41:44 CST 2023, time=2023-02-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=885331, encodeId=2e93885331b2, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿后一天就under review，20天不到审稿意见回来，一个审稿人尖锐批评，一个看似给了修改机会，最后还是拒稿，未接收转投，总体而言较难中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小笨蛋, createdTime=Tue Sep 15 00:30:03 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553552, encodeId=a1ee55355201, content=8天 with editor，只说投的文章量大，50-60%的文章不会送审，transfer给了Endocrinology和 Journal of endocrine society。哎，歇菜！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1905, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3f8108629, createdName=xiaobao111, createdTime=Sun Mar 11 21:20:00 CST 2018, time=2018-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571551, encodeId=a9d65e155113, content=审稿速度:3.0 经验分享：于2019年2月26日投稿，一篇meta，然后5月18日直接被拒，三个月啊。编者的建议主要是我纳入的中文文献库（CNKI和万方），他们无法重复。所以纳入中文文献的meta慎投这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0icicabQPFRfglHZr0mpDfC2oYjwL5n0xDc0wODUNEyWJuia9wXP3TnHwrZMktLMl7OQH7ZoUicGQHiclLb373GdibAg/132, createdBy=b44f2541766, createdName=lucifer11, createdTime=Mon May 27 16:57:00 CST 2019, time=2019-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073628, encodeId=bf4b10e3628d6, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管代谢 经验分享：一审一个月，2个审稿人，给的意见都很不错，修回编辑直接决定接收了，文章如果比较新颖，故事说的也比较完整还是很有希望的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1376, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95512077050, createdName=1321f15a85m, createdTime=Wed Nov 24 20:49:29 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582484, encodeId=8c8358248482, content=2020/01/01 revise 速度惊人；修回时间给了两个月454646258 2019-12-29 发表:: 非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers454646258 2019-12-29 00:00:00 发表: 非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers, beContent=454646258 2019-12-29 发表:: 非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers, objectType=tool_impact_factor, channel=null, level=null, likeNumber=961, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Wed Jan 01 00:00:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241699, encodeId=4fdc124169912, content=投稿后，由with editor变成了Under Review，不知道是不是送审了的意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fd51628848, createdName=cq2019, createdTime=Sun Aug 28 22:15:35 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236702, encodeId=ad361236e02e6, content=偏重的研究方向：内分泌;临床内分泌 经验分享：7.16号投稿，8.1号收到回修意见，比较友好，审稿人1只要求修改两个具有语法问题的句子，希望最后能接受吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f715652243, createdName=ms9000000283662601, createdTime=Fri Aug 05 08:32:37 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200334, encodeId=be5122003344b, content=3-30投稿，4-5under review，4-24 with editor，希望有revise, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7bfb2469150, createdName=jolin_story_47656629, createdTime=Thu Apr 25 12:38:44 CST 2024, time=2024-04-25, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1054662, encodeId=43b91054662ed, content=审稿速度:1.0 经验分享：一审一个月，两个审稿人，提的问题都很友善，提交返修后两周接收。补充材料需要上传至公共数据库并且在文中引用（第一次投稿时可以不上传）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=680, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6ec5497373, createdName=ms2000000907990850, createdTime=Sat Sep 25 10:21:26 CST 2021, time=2021-09-25, status=1, ipAttribution=)]

2020-09-15 科研小笨蛋

审稿速度:1.0 | 投稿命中率:25.0
经验分享：投稿后一天就under review，20天不到审稿意见回来，一个审稿人尖锐批评，一个看似给了修改机会，最后还是拒稿，未接收转投，总体而言较难中

377 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2116533, encodeId=287321165339b, content=投稿一天后就变成了under review，想问一下大家是编辑内审还是送外审的意思呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d725625357, createdName=ms2000000214267649, createdTime=Sun Feb 26 13:41:44 CST 2023, time=2023-02-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=885331, encodeId=2e93885331b2, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿后一天就under review，20天不到审稿意见回来，一个审稿人尖锐批评，一个看似给了修改机会，最后还是拒稿，未接收转投，总体而言较难中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小笨蛋, createdTime=Tue Sep 15 00:30:03 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553552, encodeId=a1ee55355201, content=8天 with editor，只说投的文章量大，50-60%的文章不会送审，transfer给了Endocrinology和 Journal of endocrine society。哎，歇菜！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1905, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3f8108629, createdName=xiaobao111, createdTime=Sun Mar 11 21:20:00 CST 2018, time=2018-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571551, encodeId=a9d65e155113, content=审稿速度:3.0 经验分享：于2019年2月26日投稿，一篇meta，然后5月18日直接被拒，三个月啊。编者的建议主要是我纳入的中文文献库（CNKI和万方），他们无法重复。所以纳入中文文献的meta慎投这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0icicabQPFRfglHZr0mpDfC2oYjwL5n0xDc0wODUNEyWJuia9wXP3TnHwrZMktLMl7OQH7ZoUicGQHiclLb373GdibAg/132, createdBy=b44f2541766, createdName=lucifer11, createdTime=Mon May 27 16:57:00 CST 2019, time=2019-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073628, encodeId=bf4b10e3628d6, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管代谢 经验分享：一审一个月，2个审稿人，给的意见都很不错，修回编辑直接决定接收了，文章如果比较新颖，故事说的也比较完整还是很有希望的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1376, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95512077050, createdName=1321f15a85m, createdTime=Wed Nov 24 20:49:29 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582484, encodeId=8c8358248482, content=2020/01/01 revise 速度惊人；修回时间给了两个月454646258 2019-12-29 发表:: 非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers454646258 2019-12-29 00:00:00 发表: 非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers, beContent=454646258 2019-12-29 发表:: 非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers, objectType=tool_impact_factor, channel=null, level=null, likeNumber=961, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Wed Jan 01 00:00:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241699, encodeId=4fdc124169912, content=投稿后，由with editor变成了Under Review，不知道是不是送审了的意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fd51628848, createdName=cq2019, createdTime=Sun Aug 28 22:15:35 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236702, encodeId=ad361236e02e6, content=偏重的研究方向：内分泌;临床内分泌 经验分享：7.16号投稿，8.1号收到回修意见，比较友好，审稿人1只要求修改两个具有语法问题的句子，希望最后能接受吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f715652243, createdName=ms9000000283662601, createdTime=Fri Aug 05 08:32:37 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200334, encodeId=be5122003344b, content=3-30投稿，4-5under review，4-24 with editor，希望有revise, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7bfb2469150, createdName=jolin_story_47656629, createdTime=Thu Apr 25 12:38:44 CST 2024, time=2024-04-25, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1054662, encodeId=43b91054662ed, content=审稿速度:1.0 经验分享：一审一个月，两个审稿人，提的问题都很友善，提交返修后两周接收。补充材料需要上传至公共数据库并且在文中引用（第一次投稿时可以不上传）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=680, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6ec5497373, createdName=ms2000000907990850, createdTime=Sat Sep 25 10:21:26 CST 2021, time=2021-09-25, status=1, ipAttribution=)]

2018-03-11 xiaobao111

8天 with editor，只说投的文章量大，50-60%的文章不会送审，transfer给了Endocrinology和 Journal of endocrine society。哎，歇菜！

1905 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2116533, encodeId=287321165339b, content=投稿一天后就变成了under review，想问一下大家是编辑内审还是送外审的意思呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d725625357, createdName=ms2000000214267649, createdTime=Sun Feb 26 13:41:44 CST 2023, time=2023-02-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=885331, encodeId=2e93885331b2, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿后一天就under review，20天不到审稿意见回来，一个审稿人尖锐批评，一个看似给了修改机会，最后还是拒稿，未接收转投，总体而言较难中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小笨蛋, createdTime=Tue Sep 15 00:30:03 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553552, encodeId=a1ee55355201, content=8天 with editor，只说投的文章量大，50-60%的文章不会送审，transfer给了Endocrinology和 Journal of endocrine society。哎，歇菜！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1905, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3f8108629, createdName=xiaobao111, createdTime=Sun Mar 11 21:20:00 CST 2018, time=2018-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571551, encodeId=a9d65e155113, content=审稿速度:3.0 经验分享：于2019年2月26日投稿，一篇meta，然后5月18日直接被拒，三个月啊。编者的建议主要是我纳入的中文文献库（CNKI和万方），他们无法重复。所以纳入中文文献的meta慎投这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0icicabQPFRfglHZr0mpDfC2oYjwL5n0xDc0wODUNEyWJuia9wXP3TnHwrZMktLMl7OQH7ZoUicGQHiclLb373GdibAg/132, createdBy=b44f2541766, createdName=lucifer11, createdTime=Mon May 27 16:57:00 CST 2019, time=2019-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073628, encodeId=bf4b10e3628d6, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管代谢 经验分享：一审一个月，2个审稿人，给的意见都很不错，修回编辑直接决定接收了，文章如果比较新颖，故事说的也比较完整还是很有希望的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1376, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95512077050, createdName=1321f15a85m, createdTime=Wed Nov 24 20:49:29 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582484, encodeId=8c8358248482, content=2020/01/01 revise 速度惊人；修回时间给了两个月454646258 2019-12-29 发表:: 非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers454646258 2019-12-29 00:00:00 发表: 非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers, beContent=454646258 2019-12-29 发表:: 非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers, objectType=tool_impact_factor, channel=null, level=null, likeNumber=961, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Wed Jan 01 00:00:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241699, encodeId=4fdc124169912, content=投稿后，由with editor变成了Under Review，不知道是不是送审了的意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fd51628848, createdName=cq2019, createdTime=Sun Aug 28 22:15:35 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236702, encodeId=ad361236e02e6, content=偏重的研究方向：内分泌;临床内分泌 经验分享：7.16号投稿，8.1号收到回修意见，比较友好，审稿人1只要求修改两个具有语法问题的句子，希望最后能接受吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f715652243, createdName=ms9000000283662601, createdTime=Fri Aug 05 08:32:37 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200334, encodeId=be5122003344b, content=3-30投稿，4-5under review，4-24 with editor，希望有revise, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7bfb2469150, createdName=jolin_story_47656629, createdTime=Thu Apr 25 12:38:44 CST 2024, time=2024-04-25, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1054662, encodeId=43b91054662ed, content=审稿速度:1.0 经验分享：一审一个月，两个审稿人，提的问题都很友善，提交返修后两周接收。补充材料需要上传至公共数据库并且在文中引用（第一次投稿时可以不上传）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=680, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6ec5497373, createdName=ms2000000907990850, createdTime=Sat Sep 25 10:21:26 CST 2021, time=2021-09-25, status=1, ipAttribution=)]

2019-05-27 lucifer11

审稿速度:3.0
经验分享：于2019年2月26日投稿，一篇meta，然后5月18日直接被拒，三个月啊。编者的建议主要是我纳入的中文文献库（CNKI和万方），他们无法重复。所以纳入中文文献的meta慎投这个杂志。

156 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2116533, encodeId=287321165339b, content=投稿一天后就变成了under review，想问一下大家是编辑内审还是送外审的意思呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d725625357, createdName=ms2000000214267649, createdTime=Sun Feb 26 13:41:44 CST 2023, time=2023-02-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=885331, encodeId=2e93885331b2, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿后一天就under review，20天不到审稿意见回来，一个审稿人尖锐批评，一个看似给了修改机会，最后还是拒稿，未接收转投，总体而言较难中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小笨蛋, createdTime=Tue Sep 15 00:30:03 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553552, encodeId=a1ee55355201, content=8天 with editor，只说投的文章量大，50-60%的文章不会送审，transfer给了Endocrinology和 Journal of endocrine society。哎，歇菜！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1905, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3f8108629, createdName=xiaobao111, createdTime=Sun Mar 11 21:20:00 CST 2018, time=2018-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571551, encodeId=a9d65e155113, content=审稿速度:3.0 经验分享：于2019年2月26日投稿，一篇meta，然后5月18日直接被拒，三个月啊。编者的建议主要是我纳入的中文文献库（CNKI和万方），他们无法重复。所以纳入中文文献的meta慎投这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0icicabQPFRfglHZr0mpDfC2oYjwL5n0xDc0wODUNEyWJuia9wXP3TnHwrZMktLMl7OQH7ZoUicGQHiclLb373GdibAg/132, createdBy=b44f2541766, createdName=lucifer11, createdTime=Mon May 27 16:57:00 CST 2019, time=2019-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073628, encodeId=bf4b10e3628d6, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管代谢 经验分享：一审一个月，2个审稿人，给的意见都很不错，修回编辑直接决定接收了，文章如果比较新颖，故事说的也比较完整还是很有希望的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1376, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95512077050, createdName=1321f15a85m, createdTime=Wed Nov 24 20:49:29 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582484, encodeId=8c8358248482, content=2020/01/01 revise 速度惊人；修回时间给了两个月454646258 2019-12-29 发表:: 非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers454646258 2019-12-29 00:00:00 发表: 非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers, beContent=454646258 2019-12-29 发表:: 非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers, objectType=tool_impact_factor, channel=null, level=null, likeNumber=961, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Wed Jan 01 00:00:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241699, encodeId=4fdc124169912, content=投稿后，由with editor变成了Under Review，不知道是不是送审了的意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fd51628848, createdName=cq2019, createdTime=Sun Aug 28 22:15:35 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236702, encodeId=ad361236e02e6, content=偏重的研究方向：内分泌;临床内分泌 经验分享：7.16号投稿，8.1号收到回修意见，比较友好，审稿人1只要求修改两个具有语法问题的句子，希望最后能接受吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f715652243, createdName=ms9000000283662601, createdTime=Fri Aug 05 08:32:37 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200334, encodeId=be5122003344b, content=3-30投稿，4-5under review，4-24 with editor，希望有revise, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7bfb2469150, createdName=jolin_story_47656629, createdTime=Thu Apr 25 12:38:44 CST 2024, time=2024-04-25, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1054662, encodeId=43b91054662ed, content=审稿速度:1.0 经验分享：一审一个月，两个审稿人，提的问题都很友善，提交返修后两周接收。补充材料需要上传至公共数据库并且在文中引用（第一次投稿时可以不上传）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=680, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6ec5497373, createdName=ms2000000907990850, createdTime=Sat Sep 25 10:21:26 CST 2021, time=2021-09-25, status=1, ipAttribution=)]

2021-11-24 1321f15a85m

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：心血管代谢
经验分享：一审一个月，2个审稿人，给的意见都很不错，修回编辑直接决定接收了，文章如果比较新颖，故事说的也比较完整还是很有希望的！

1376 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2116533, encodeId=287321165339b, content=投稿一天后就变成了under review，想问一下大家是编辑内审还是送外审的意思呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d725625357, createdName=ms2000000214267649, createdTime=Sun Feb 26 13:41:44 CST 2023, time=2023-02-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=885331, encodeId=2e93885331b2, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿后一天就under review，20天不到审稿意见回来，一个审稿人尖锐批评，一个看似给了修改机会，最后还是拒稿，未接收转投，总体而言较难中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小笨蛋, createdTime=Tue Sep 15 00:30:03 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553552, encodeId=a1ee55355201, content=8天 with editor，只说投的文章量大，50-60%的文章不会送审，transfer给了Endocrinology和 Journal of endocrine society。哎，歇菜！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1905, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3f8108629, createdName=xiaobao111, createdTime=Sun Mar 11 21:20:00 CST 2018, time=2018-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571551, encodeId=a9d65e155113, content=审稿速度:3.0 经验分享：于2019年2月26日投稿，一篇meta，然后5月18日直接被拒，三个月啊。编者的建议主要是我纳入的中文文献库（CNKI和万方），他们无法重复。所以纳入中文文献的meta慎投这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0icicabQPFRfglHZr0mpDfC2oYjwL5n0xDc0wODUNEyWJuia9wXP3TnHwrZMktLMl7OQH7ZoUicGQHiclLb373GdibAg/132, createdBy=b44f2541766, createdName=lucifer11, createdTime=Mon May 27 16:57:00 CST 2019, time=2019-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073628, encodeId=bf4b10e3628d6, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管代谢 经验分享：一审一个月，2个审稿人，给的意见都很不错，修回编辑直接决定接收了，文章如果比较新颖，故事说的也比较完整还是很有希望的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1376, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95512077050, createdName=1321f15a85m, createdTime=Wed Nov 24 20:49:29 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582484, encodeId=8c8358248482, content=2020/01/01 revise 速度惊人；修回时间给了两个月454646258 2019-12-29 发表:: 非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers454646258 2019-12-29 00:00:00 发表: 非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers, beContent=454646258 2019-12-29 发表:: 非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers, objectType=tool_impact_factor, channel=null, level=null, likeNumber=961, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Wed Jan 01 00:00:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241699, encodeId=4fdc124169912, content=投稿后，由with editor变成了Under Review，不知道是不是送审了的意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fd51628848, createdName=cq2019, createdTime=Sun Aug 28 22:15:35 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236702, encodeId=ad361236e02e6, content=偏重的研究方向：内分泌;临床内分泌 经验分享：7.16号投稿，8.1号收到回修意见，比较友好，审稿人1只要求修改两个具有语法问题的句子，希望最后能接受吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f715652243, createdName=ms9000000283662601, createdTime=Fri Aug 05 08:32:37 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200334, encodeId=be5122003344b, content=3-30投稿，4-5under review，4-24 with editor，希望有revise, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7bfb2469150, createdName=jolin_story_47656629, createdTime=Thu Apr 25 12:38:44 CST 2024, time=2024-04-25, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1054662, encodeId=43b91054662ed, content=审稿速度:1.0 经验分享：一审一个月，两个审稿人，提的问题都很友善，提交返修后两周接收。补充材料需要上传至公共数据库并且在文中引用（第一次投稿时可以不上传）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=680, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6ec5497373, createdName=ms2000000907990850, createdTime=Sat Sep 25 10:21:26 CST 2021, time=2021-09-25, status=1, ipAttribution=)]

2020-01-01 454646258

2020/01/01 revise 速度惊人；修回时间给了两个月454646258 2019-12-29 发表::
非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers454646258 2019-12-29 00:00:00 发表:
非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers

454646258 2019-12-29 发表:: 非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers

961 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2116533, encodeId=287321165339b, content=投稿一天后就变成了under review，想问一下大家是编辑内审还是送外审的意思呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d725625357, createdName=ms2000000214267649, createdTime=Sun Feb 26 13:41:44 CST 2023, time=2023-02-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=885331, encodeId=2e93885331b2, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿后一天就under review，20天不到审稿意见回来，一个审稿人尖锐批评，一个看似给了修改机会，最后还是拒稿，未接收转投，总体而言较难中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小笨蛋, createdTime=Tue Sep 15 00:30:03 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553552, encodeId=a1ee55355201, content=8天 with editor，只说投的文章量大，50-60%的文章不会送审，transfer给了Endocrinology和 Journal of endocrine society。哎，歇菜！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1905, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3f8108629, createdName=xiaobao111, createdTime=Sun Mar 11 21:20:00 CST 2018, time=2018-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571551, encodeId=a9d65e155113, content=审稿速度:3.0 经验分享：于2019年2月26日投稿，一篇meta，然后5月18日直接被拒，三个月啊。编者的建议主要是我纳入的中文文献库（CNKI和万方），他们无法重复。所以纳入中文文献的meta慎投这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0icicabQPFRfglHZr0mpDfC2oYjwL5n0xDc0wODUNEyWJuia9wXP3TnHwrZMktLMl7OQH7ZoUicGQHiclLb373GdibAg/132, createdBy=b44f2541766, createdName=lucifer11, createdTime=Mon May 27 16:57:00 CST 2019, time=2019-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073628, encodeId=bf4b10e3628d6, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管代谢 经验分享：一审一个月，2个审稿人，给的意见都很不错，修回编辑直接决定接收了，文章如果比较新颖，故事说的也比较完整还是很有希望的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1376, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95512077050, createdName=1321f15a85m, createdTime=Wed Nov 24 20:49:29 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582484, encodeId=8c8358248482, content=2020/01/01 revise 速度惊人；修回时间给了两个月454646258 2019-12-29 发表:: 非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers454646258 2019-12-29 00:00:00 发表: 非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers, beContent=454646258 2019-12-29 发表:: 非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers, objectType=tool_impact_factor, channel=null, level=null, likeNumber=961, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Wed Jan 01 00:00:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241699, encodeId=4fdc124169912, content=投稿后，由with editor变成了Under Review，不知道是不是送审了的意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fd51628848, createdName=cq2019, createdTime=Sun Aug 28 22:15:35 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236702, encodeId=ad361236e02e6, content=偏重的研究方向：内分泌;临床内分泌 经验分享：7.16号投稿，8.1号收到回修意见，比较友好，审稿人1只要求修改两个具有语法问题的句子，希望最后能接受吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f715652243, createdName=ms9000000283662601, createdTime=Fri Aug 05 08:32:37 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200334, encodeId=be5122003344b, content=3-30投稿，4-5under review，4-24 with editor，希望有revise, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7bfb2469150, createdName=jolin_story_47656629, createdTime=Thu Apr 25 12:38:44 CST 2024, time=2024-04-25, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1054662, encodeId=43b91054662ed, content=审稿速度:1.0 经验分享：一审一个月，两个审稿人，提的问题都很友善，提交返修后两周接收。补充材料需要上传至公共数据库并且在文中引用（第一次投稿时可以不上传）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=680, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6ec5497373, createdName=ms2000000907990850, createdTime=Sat Sep 25 10:21:26 CST 2021, time=2021-09-25, status=1, ipAttribution=)]

2022-08-28 cq2019

投稿后，由with editor变成了Under Review，不知道是不是送审了的意思

299 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2116533, encodeId=287321165339b, content=投稿一天后就变成了under review，想问一下大家是编辑内审还是送外审的意思呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d725625357, createdName=ms2000000214267649, createdTime=Sun Feb 26 13:41:44 CST 2023, time=2023-02-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=885331, encodeId=2e93885331b2, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿后一天就under review，20天不到审稿意见回来，一个审稿人尖锐批评，一个看似给了修改机会，最后还是拒稿，未接收转投，总体而言较难中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小笨蛋, createdTime=Tue Sep 15 00:30:03 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553552, encodeId=a1ee55355201, content=8天 with editor，只说投的文章量大，50-60%的文章不会送审，transfer给了Endocrinology和 Journal of endocrine society。哎，歇菜！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1905, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3f8108629, createdName=xiaobao111, createdTime=Sun Mar 11 21:20:00 CST 2018, time=2018-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571551, encodeId=a9d65e155113, content=审稿速度:3.0 经验分享：于2019年2月26日投稿，一篇meta，然后5月18日直接被拒，三个月啊。编者的建议主要是我纳入的中文文献库（CNKI和万方），他们无法重复。所以纳入中文文献的meta慎投这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0icicabQPFRfglHZr0mpDfC2oYjwL5n0xDc0wODUNEyWJuia9wXP3TnHwrZMktLMl7OQH7ZoUicGQHiclLb373GdibAg/132, createdBy=b44f2541766, createdName=lucifer11, createdTime=Mon May 27 16:57:00 CST 2019, time=2019-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073628, encodeId=bf4b10e3628d6, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管代谢 经验分享：一审一个月，2个审稿人，给的意见都很不错，修回编辑直接决定接收了，文章如果比较新颖，故事说的也比较完整还是很有希望的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1376, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95512077050, createdName=1321f15a85m, createdTime=Wed Nov 24 20:49:29 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582484, encodeId=8c8358248482, content=2020/01/01 revise 速度惊人；修回时间给了两个月454646258 2019-12-29 发表:: 非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers454646258 2019-12-29 00:00:00 发表: 非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers, beContent=454646258 2019-12-29 发表:: 非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers, objectType=tool_impact_factor, channel=null, level=null, likeNumber=961, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Wed Jan 01 00:00:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241699, encodeId=4fdc124169912, content=投稿后，由with editor变成了Under Review，不知道是不是送审了的意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fd51628848, createdName=cq2019, createdTime=Sun Aug 28 22:15:35 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236702, encodeId=ad361236e02e6, content=偏重的研究方向：内分泌;临床内分泌 经验分享：7.16号投稿，8.1号收到回修意见，比较友好，审稿人1只要求修改两个具有语法问题的句子，希望最后能接受吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f715652243, createdName=ms9000000283662601, createdTime=Fri Aug 05 08:32:37 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200334, encodeId=be5122003344b, content=3-30投稿，4-5under review，4-24 with editor，希望有revise, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7bfb2469150, createdName=jolin_story_47656629, createdTime=Thu Apr 25 12:38:44 CST 2024, time=2024-04-25, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1054662, encodeId=43b91054662ed, content=审稿速度:1.0 经验分享：一审一个月，两个审稿人，提的问题都很友善，提交返修后两周接收。补充材料需要上传至公共数据库并且在文中引用（第一次投稿时可以不上传）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=680, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6ec5497373, createdName=ms2000000907990850, createdTime=Sat Sep 25 10:21:26 CST 2021, time=2021-09-25, status=1, ipAttribution=)]

2022-08-05 ms9000000283662601

偏重的研究方向：内分泌;临床内分泌
经验分享：7.16号投稿，8.1号收到回修意见，比较友好，审稿人1只要求修改两个具有语法问题的句子，希望最后能接受吧！

388 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2116533, encodeId=287321165339b, content=投稿一天后就变成了under review，想问一下大家是编辑内审还是送外审的意思呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d725625357, createdName=ms2000000214267649, createdTime=Sun Feb 26 13:41:44 CST 2023, time=2023-02-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=885331, encodeId=2e93885331b2, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿后一天就under review，20天不到审稿意见回来，一个审稿人尖锐批评，一个看似给了修改机会，最后还是拒稿，未接收转投，总体而言较难中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小笨蛋, createdTime=Tue Sep 15 00:30:03 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553552, encodeId=a1ee55355201, content=8天 with editor，只说投的文章量大，50-60%的文章不会送审，transfer给了Endocrinology和 Journal of endocrine society。哎，歇菜！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1905, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3f8108629, createdName=xiaobao111, createdTime=Sun Mar 11 21:20:00 CST 2018, time=2018-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571551, encodeId=a9d65e155113, content=审稿速度:3.0 经验分享：于2019年2月26日投稿，一篇meta，然后5月18日直接被拒，三个月啊。编者的建议主要是我纳入的中文文献库（CNKI和万方），他们无法重复。所以纳入中文文献的meta慎投这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0icicabQPFRfglHZr0mpDfC2oYjwL5n0xDc0wODUNEyWJuia9wXP3TnHwrZMktLMl7OQH7ZoUicGQHiclLb373GdibAg/132, createdBy=b44f2541766, createdName=lucifer11, createdTime=Mon May 27 16:57:00 CST 2019, time=2019-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073628, encodeId=bf4b10e3628d6, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管代谢 经验分享：一审一个月，2个审稿人，给的意见都很不错，修回编辑直接决定接收了，文章如果比较新颖，故事说的也比较完整还是很有希望的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1376, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95512077050, createdName=1321f15a85m, createdTime=Wed Nov 24 20:49:29 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582484, encodeId=8c8358248482, content=2020/01/01 revise 速度惊人；修回时间给了两个月454646258 2019-12-29 发表:: 非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers454646258 2019-12-29 00:00:00 发表: 非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers, beContent=454646258 2019-12-29 发表:: 非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers, objectType=tool_impact_factor, channel=null, level=null, likeNumber=961, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Wed Jan 01 00:00:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241699, encodeId=4fdc124169912, content=投稿后，由with editor变成了Under Review，不知道是不是送审了的意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fd51628848, createdName=cq2019, createdTime=Sun Aug 28 22:15:35 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236702, encodeId=ad361236e02e6, content=偏重的研究方向：内分泌;临床内分泌 经验分享：7.16号投稿，8.1号收到回修意见，比较友好，审稿人1只要求修改两个具有语法问题的句子，希望最后能接受吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f715652243, createdName=ms9000000283662601, createdTime=Fri Aug 05 08:32:37 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200334, encodeId=be5122003344b, content=3-30投稿，4-5under review，4-24 with editor，希望有revise, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7bfb2469150, createdName=jolin_story_47656629, createdTime=Thu Apr 25 12:38:44 CST 2024, time=2024-04-25, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1054662, encodeId=43b91054662ed, content=审稿速度:1.0 经验分享：一审一个月，两个审稿人，提的问题都很友善，提交返修后两周接收。补充材料需要上传至公共数据库并且在文中引用（第一次投稿时可以不上传）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=680, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6ec5497373, createdName=ms2000000907990850, createdTime=Sat Sep 25 10:21:26 CST 2021, time=2021-09-25, status=1, ipAttribution=)]

2024-04-25 jolin_story_47656629 来自云南省

3-30投稿，4-5under review，4-24 with editor，希望有revise

4 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2116533, encodeId=287321165339b, content=投稿一天后就变成了under review，想问一下大家是编辑内审还是送外审的意思呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d725625357, createdName=ms2000000214267649, createdTime=Sun Feb 26 13:41:44 CST 2023, time=2023-02-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=885331, encodeId=2e93885331b2, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿后一天就under review，20天不到审稿意见回来，一个审稿人尖锐批评，一个看似给了修改机会，最后还是拒稿，未接收转投，总体而言较难中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小笨蛋, createdTime=Tue Sep 15 00:30:03 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553552, encodeId=a1ee55355201, content=8天 with editor，只说投的文章量大，50-60%的文章不会送审，transfer给了Endocrinology和 Journal of endocrine society。哎，歇菜！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1905, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3f8108629, createdName=xiaobao111, createdTime=Sun Mar 11 21:20:00 CST 2018, time=2018-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571551, encodeId=a9d65e155113, content=审稿速度:3.0 经验分享：于2019年2月26日投稿，一篇meta，然后5月18日直接被拒，三个月啊。编者的建议主要是我纳入的中文文献库（CNKI和万方），他们无法重复。所以纳入中文文献的meta慎投这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0icicabQPFRfglHZr0mpDfC2oYjwL5n0xDc0wODUNEyWJuia9wXP3TnHwrZMktLMl7OQH7ZoUicGQHiclLb373GdibAg/132, createdBy=b44f2541766, createdName=lucifer11, createdTime=Mon May 27 16:57:00 CST 2019, time=2019-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073628, encodeId=bf4b10e3628d6, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管代谢 经验分享：一审一个月，2个审稿人，给的意见都很不错，修回编辑直接决定接收了，文章如果比较新颖，故事说的也比较完整还是很有希望的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1376, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95512077050, createdName=1321f15a85m, createdTime=Wed Nov 24 20:49:29 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582484, encodeId=8c8358248482, content=2020/01/01 revise 速度惊人；修回时间给了两个月454646258 2019-12-29 发表:: 非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers454646258 2019-12-29 00:00:00 发表: 非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers, beContent=454646258 2019-12-29 发表:: 非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers, objectType=tool_impact_factor, channel=null, level=null, likeNumber=961, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Wed Jan 01 00:00:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241699, encodeId=4fdc124169912, content=投稿后，由with editor变成了Under Review，不知道是不是送审了的意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fd51628848, createdName=cq2019, createdTime=Sun Aug 28 22:15:35 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236702, encodeId=ad361236e02e6, content=偏重的研究方向：内分泌;临床内分泌 经验分享：7.16号投稿，8.1号收到回修意见，比较友好，审稿人1只要求修改两个具有语法问题的句子，希望最后能接受吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f715652243, createdName=ms9000000283662601, createdTime=Fri Aug 05 08:32:37 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200334, encodeId=be5122003344b, content=3-30投稿，4-5under review，4-24 with editor，希望有revise, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7bfb2469150, createdName=jolin_story_47656629, createdTime=Thu Apr 25 12:38:44 CST 2024, time=2024-04-25, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1054662, encodeId=43b91054662ed, content=审稿速度:1.0 经验分享：一审一个月，两个审稿人，提的问题都很友善，提交返修后两周接收。补充材料需要上传至公共数据库并且在文中引用（第一次投稿时可以不上传）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=680, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6ec5497373, createdName=ms2000000907990850, createdTime=Sat Sep 25 10:21:26 CST 2021, time=2021-09-25, status=1, ipAttribution=)]

2021-09-25 ms2000000907990850

审稿速度:1.0
经验分享：一审一个月，两个审稿人，提的问题都很友善，提交返修后两周接收。补充材料需要上传至公共数据库并且在文中引用（第一次投稿时可以不上传）。

680 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务